| 122 |
Classification of TB on the basis of Drug Resistance |
Pending Review |
06/03/2022 |
| 513 |
Drug-resistant Tuberculosis |
Pending Review |
06/03/2022 |
| 510 |
TB Infection Vs Active TB Disease |
Live |
06/03/2022 |
| 24 |
Request for TB tests |
Live |
17/02/2022 |
| 144 |
Sputum Collection centres |
Live |
16/02/2022 |
| 64 |
Genotypic Tests |
Pending Review |
16/02/2022 |
| 193 |
EQA for Microscopy LTs |
Live |
16/02/2022 |
| 192 |
General Concepts in Microscopy quality assurance |
Live |
16/02/2022 |
| 63 |
Phenotypic Tests |
Pending Review |
16/02/2022 |
| 131 |
Continuum of TB Care |
Live |
16/02/2022 |
| 130 |
Burden of TB in India |
Live |
16/02/2022 |
| 314 |
Nomenclature of Mycobacterium tuberculosis [M.tb] |
Live |
14/02/2022 |
| 457 |
CBNAAT Xpert MTB/RIF - Indications of use under NTEP |
Live |
14/02/2022 |
| 395 |
CBNAAT Xpert MTB/RIF Assay/Cartridge |
Live |
14/02/2022 |
| 12 |
Stages in TB Patient's Lifecycle |
Live |
13/02/2022 |
| 396 |
CBNAAT Xpert Ultra Assay/Cartridge |
Pending Review |
09/02/2022 |
| 145 |
Principles of TB Diagnosis under NTEP |
Live |
30/01/2022 |
| 23 |
General process flow for testing in NTEP |
Live |
30/01/2022 |
| 143 |
NAAT Labs and their role |
Live |
30/01/2022 |
| 380 |
Norms and requirements of a DMC |
Live |
30/01/2022 |
| 105 |
District TB Centre [DTC] |
Live |
30/01/2022 |
| 142 |
CDST labs and their role |
Live |
30/01/2022 |
| 104 |
The State TB Cell |
Live |
30/01/2022 |
| 102 |
National Institutes |
Live |
30/01/2022 |
| 103 |
Central TB Division [CTD] |
Live |
30/01/2022 |
| 50 |
Health System Integration |
Live |
30/01/2022 |
| 113 |
India's commitment to End TB |
Live |
29/01/2022 |
| 359 |
Development of Drug Resistance in Mtb. |
Live |
29/01/2022 |
| 334 |
Agent in TB |
Live |
29/01/2022 |
| 356 |
Global Burden of TB-HIV |
Live |
29/01/2022 |
